Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 104, Issue 1, 2014, Pages 171-175

  Yuksel, Mehmet Aytac ^a   Oncul, Mahmut ^a   Tuten, Abdullah ^a   Imamoglu, Metehan ^a   Acikgoz, Abdullah Serdar ^a   Kucur, Mine ^a   Madazli, Riza ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cord blood; Gestational diabetes mellitus; Irisin; Maternal

Indexed keywords

HORMONE; IRISIN; UNCLASSIFIED DRUG; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD GLUCOSE MONITORING; BODY HEIGHT; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MATERNAL SERUM; PREGNANCY DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; UMBILICAL CORD BLOOD; BLOOD; FETUS BLOOD; FOLLOW UP; METABOLISM; NEWBORN; PREGNANCY; RETROSPECTIVE STUDY;

ADULT; BIRTH WEIGHT; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; FIBRONECTINS; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 84898539259     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.12.025     Document Type: Article

References (19)

1. ACOG Practice Bulletin Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 2001, 98:525-538.
2. Catalano P.M., Kirwan J.P., Haugel-de Mouzon S., King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003, 133:1674S-1683S.
3. Pedersen B.K., Febbraio M.A. Muscles exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012, 8:457-465.
4. Bostrom P., Wu J., Jedrychowski M.P., Korde A., Ye L., Lo J.C., et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
5. Hojlund K., Bostrom P. Irisin in obesity and type 2 diabetes. J Diabetes Complications 2013, 27:303-304.
6. Liu J.J., Wong M.D., Toy W.C., Tan C.S., Liu S., Ng X.W., et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 2013, 27:365-369.
7. Choi Y.K., Kim M.K., Bae K.H., Seo H.A., Jeong J.Y., Lee W.K., et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 2013, 100:96-101.
8. Carpenter M.W., Coustan D.R. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982, 144:768-773.
9. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
10. Stengel A., Hofmann T., Goebel-Stengel M., Elbelt U., Kobelt P., Klapp B.F. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 2013, 39:125-130.
11. Wen M.S., Wang C.Y., Lin S.L., Hung K.C. Decrease in irisin in patients with chronic kidney disease. PLoS One 2013, 8:e64025.
12. Seale P., Conroe H.M., Estall J., Kajimura S., Frontini A., Ishibashi J., et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 2011, 121:96-105.
13. Enerback S. Human brown adipose tissue. Cell Metab 2010, 11:248-252.
14. Kelly D.P. Medicine. Irisin, light my fire. Science 2012, 336:42-43.
15. Villarroya F. Irisin, turning up the heat. Cell Metab 2012, 15:277-278.
16. Liang H., Ward W.F. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ 2006, 30:145-151.
17. Timmons J.A., Baar K., Davidsen P.K., Atherton P.J. Is irisin a human exercise gene?. Nature 2012, 488:E9-E10. discussion E-1.
18. Huh J.Y., Panagiotou G., Mougios V., Brinkoetter M., Vamvini M.T., Schneider B.E., et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012, 61:1725-1738.
19. Moreno-Navarrete J.M., Ortega F., Serrano M., Guerra E., Pardo G., Tinahones F., et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013, 98:E769-E778.